4-Substituted indazoles as new inhibitors of neuronal nitric oxide synthase

Bioorganic and Medicinal Chemistry Letters

Volumn 17, Issue 11, 2007, Pages 3177-3180

  Boulouard, Michel ^a   Schumann Bard, Pascale ^a,b   Butt Gueulle, Sabrina ^a   Lohou, Elodie ^a   Stiebing, Silvia ^a   Collot, Valérie ^a   Rault, Sylvain ^a  

^a CENTRE D ETUDES ET DE RECHERCHE SUR LE MÉDICAMENT DE NORMANDIE   (France)

^b UNIVERSITÉ DE CAEN   (France)

Author keywords

Antinociceptive; Indazole; Inhibitor; Neuronal nitric oxide synthase; Nitric oxide

Indexed keywords

4 BROMOINDAZOLE; 4 NITROINDAZOLE; 7 CHLOROINDAZOLE; 7 NITROINDAZOLE; INDAZOLE DERIVATIVE; NITRIC OXIDE SYNTHASE; UNCLASSIFIED DRUG;

ARTICLE; DRUG STRUCTURE; DRUG SYNTHESIS; IC 50; IN VIVO STUDY;

ANIMALS; BROMINE; CEREBELLUM; ENZYME INHIBITORS; INDAZOLES; NEURONS; NITRIC OXIDE SYNTHASE TYPE I; RATS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 34247842964     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2007.03.024     Document Type: Article

References (26)

1. Kiss J.P., and Vizi E.S. Trends Neurosci. 24 (2001) 211
2. Kadekaro M., and Summy-Long J.Y. Clin. Exp. Pharmacol. Physiol. 27 (2000) 450
3. Bredt D.S. Free Radical Res. 31 (1999) 577
4. Cheshire D.R. IDrugs. 4 (2001) 795
5. Endres M., Laufs U., Liao J.K., and Moskowitz M.A. Trends Neurosci. 27 (2004) 283
6. Togo T., Katsuse O., and Iseki E. Neurol. Res. 26 (2004) 563
7. Stuehr D.J. Annu. Rev. Pharmacol. Toxicol. 37 (1997) 339
8. Moore P.K., Oluyomi A.O., Babbedge R.C., Wallace P., and Hart S.L. Br. J. Pharmacol. 102 (1991) 198
9. Moore P.K., Wallace P., Gaffen Z., Hart S.L., and Babbedge R.C. Br. J. Pharmacol. 110 (1993) 219
10. Parmentier S., Bohme G.A., Lerouet D., Damour D., Stutzmann J.M., Margaill I., and Plotkine M. Br. J. Pharmacol. 27 (1999) 546
11. Erdal E.P., Litzinger E.A., Seo J., Zhu Y., Ji H., and Silverman R.B. Curr. Top. Med. Chem. 5 (2005) 603
12. Dwyer M.A., Bredt D.S., and Snyder S.H. Biochem. Biophys. Res. Commun. 176 (1991) 1136
13. Babbedge R.C., Bland-Ward P.A., Hart S.L., and Moore P.K. Br. J. Pharmacol. 110 (1993) 225
14. Schumann P., Collot V., Hommet Y., Gsell W., Dauphin F., Sopkova J., MacKenzie E., Duval D., Boulouard M., and Rault S. Bioorg. Med. Chem. Lett. 11 (2001) 1153
15. Tuynman A., Pérollier C., Frapart Y., Schumann P., Collot V., Rault S., and Boucher J.-L. Nitric Oxide 9 (2003) 86
16. Elderfield R.C. In: Elderfield R.C. (Ed). Heterocyclic Compounds Vol. 5 (1957), John Wiley & Sons, Inc., New York 162
17. Behr L.C., Fusco R., and Jarobe C.H. In: Wiley R.H. (Ed). Pyrazoles, Pyrazolines, Pyrazolidines, Indazoles and Condensed Rings (1969), International Wiley Science, New York 289
18. Elguero J. In: Katritzky A.R., and Rees C.W. (Eds). Comprehensive Heterocyclic Chemistry Vol. 5 (1984), Pergamon Press, New York 167
19. Lukin K., Hsu M.C., Fernando D., and Leanna M.R. J. Org. Chem. 71 (2006) 8166
20. Bartsch R.A., and Yang I.W. J. Heterocycl. Chem. 21 (1984) 1063
21. Crestey F., Collot V., Stiebing S., and Rault S. Synthesis (2006) 3506
22. + 243.9498; found: 243.9486.
23. + 243.9498; found: 243.9488.
24. Collot V., Sopkova-De Oliveira Santos J., Schumann P., Colloc'h N., MacKenzie E., and Rault S. J. Enzyme Inhib. 18 (2003) 195
25. Sopkova-De Oliveira Santos J., Collot V., and Rault S. Acta Cryst. C 58 (2002) 688
26. Koster R., Anderson M., and de Beer E.J. Fed. Proc. 18 (1959) 412